GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Ending Cash Position

Schott Pharma AG KGaA (CHIX:1SXPD) Ending Cash Position : €22.2 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Ending Cash Position?

Schott Pharma AG KGaA's Ending Cash Position for the quarter that ended in Jun. 2024 was €22.2 Mil.

Schott Pharma AG KGaA's quarterly Ending Cash Position declined from Dec. 2023 (€21.3 Mil) to Mar. 2024 (€19.0 Mil) but then increased from Mar. 2024 (€19.0 Mil) to Jun. 2024 (€22.2 Mil).

Schott Pharma AG KGaA's annual Ending Cash Position increased from Sep. 2021 (€27.9 Mil) to Sep. 2022 (€28.8 Mil) but then declined from Sep. 2022 (€28.8 Mil) to Sep. 2023 (€24.4 Mil).

Schott Pharma AG KGaA Ending Cash Position Historical Data

The historical data trend for Schott Pharma AG KGaA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Ending Cash Position Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Ending Cash Position
18.61 27.86 28.80 24.36

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 20.90 24.36 21.34 19.02 22.15

Schott Pharma AG KGaA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Schott Pharma AG KGaA's Ending Cash Position for the fiscal year that ended in Sep. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=28.795+-4.438
=24.4

Schott Pharma AG KGaA's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=19.015+3.138
=22.2

Schott Pharma AG KGaA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Ending Cash Position
Comparable Companies
Traded in Other Exchanges
1SXP:Germany 1SXP:Austria
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines